Skip to main content

Anti-Myelin Oligodendrocyte Glycoprotein (MOG), Spinal Fluid

CPT 86362

Test Details

Methodology

Immunofluorescence (IFA)

Result Turnaround Time

3 - 5 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Special Instructions

If reflex test is performed, additional charges/CPT code(s) may apply.

Limitations

MOG IgG antibody titers may assist in monitoring disease course and prognosis, but their role is imperfect. Antibody titers may increase but may not be predictive of relapses or attacks. MOG IgG antibodies may become undetectable with immunosuppression, but this does not necessarily indicate clinical response.

Results should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Requirements

Specimen

Cerebrospinal fluid (CSF)

Volume

2 mL

Minimum Volume

1 mL (Note: This volume does not allow for repeat testing.)

Container

CSF sterile tube

Collection Instructions

Collect CSF in a sterile tube.

Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/thaw cycles

Stable x3

Storage Instructions

Room temperature

References

Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromylitis optica. Ann Neurol. 2010 Nov;68(5):757-761.21031587
Hyun JW, Woodhall MR, Kim SH, et al. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):811-817.28684532
Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation. 2016 Sep 26;13(1):279.27788675
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 Dec;364(9451):2106-2112.15589308
Peschi P, Bradl M, Hoftberger R, Berger T, Reindi M. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases. Front Immunol. 2017 May 8;8:529.28533781
Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporine 4 expression. Arch Neurol. 2006 Jul;63(7):964-968.16831965
Reindl M, Jarius S, Rostasy K, Berger T. Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they? Curr Opin Neurol. 2017 Jun;30(3):295-301.28248700
Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012 Feb 28;78(9):665-671; disussion 669.22302543
Waters P, Woodhall M, O'Connor KC, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89.25821844
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-189.26092914
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep;6(9):805-815.17706564

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
505776 Anti-MOG, CSF 91543-9 505777 Anti-MOG, CSF, Cell-based IFA 91543-9
Order Code505776
Order Code NameAnti-MOG, CSF
Order Loinc91543-9
Result Code505777
Result Code NameAnti-MOG, CSF, Cell-based IFA
UofM
Result LOINC91543-9
Reflex Table for Anti-MOG, CSF, Cell-based IFA
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 505778 Anti-MOG, CSF, Titer 505778 Anti-MOG, CSF, Titer 91542-1
Reflex 1
Order Code505778
Order NameAnti-MOG, CSF, Titer
Result Code505778
Result NameAnti-MOG, CSF, Titer
UofM
Result LOINC91542-1